Clinique is diving deeper into its dermatological roots.

The Estée Lauder Cos.-owned skincare brand has made a philanthropic commitment of $5 million over seven years to determine the Mount Sinai-Clinique Healthy Skin Dermatology Centre with Icahn School of Medicine at Mount Sinai. It should study how skin ages, skin allergies and inflammatory eczematous skin conditions, including eczema and make contact with dermatitis.

Through investigating healthy skin, together with the skin of those with atopic dermatitis and other allergic skin disorders, the hope is that researchers may learn tips on how to significantly slow the visible signs of aging in all people in addition to in patients with eczema, who show signs of premature or accelerated aging.

Insights from this research aim to spur advances in the sector of dermatology and skin health and may also inform and encourage Clinique in future product innovation to supply further solutions for individuals with allergic or sensitive skin.

“Years of chronic inflamed skin plays a task in premature aging. Extensive research has helped us understand the molecular map of skin conditions related to allergy similar to eczema and make contact with dermatitis, and we’re now at a pivotal point in addressing these conditions and more,” said Dr. Emma Guttman, Waldman professor and system chair of the  Department of Dermatology on the Icahn School of Medicine. “With Clinique’s support, we’ll proceed to actively explore targeted approaches to reversing eczematous and allergic skin conditions with the goal of making and sustaining healthy skin.”

In an interview with WWD, Clinique’s global brand president Michelle Freyre noted that sensitive skin concerns amongst consumers have surged for the reason that pandemic.

“Sensitive skin is absolutely a world phenomenon. It’s affecting a reported 71 percent of adults within the U.S. alone. Over 50 percent of dermatologist patients are self diagnosed with sensitive skin and in China sensitive skin is the number-one most treated skin concern amongst dermatologists,” she said. “We consider it’s going proceed to speed up globally in order that’s one reason why we deeply care about this work.”

The move also marks somewhat of a full-circle moment for the brand, whose founding dermatologist back within the ’60s was Dr. Norman Orentreich. His son and certainly one of Clinique’s current guiding dermatologists, Dr. David Orentreich, introduced Clinique’s head of product development to Dr. Guttman. The meeting sparked the concept for the creation of the middle, which Dr. Guttman will oversee. Her work has led to novel therapeutic targets for patients affected by inflammatory skin conditions. 

“Once we began learning about her and her world-renowned expertise in allergy and inflammatory skin diseases we thought that is such a natural continuation of our brand mission to create great skin, but additionally really supporting something that’s really meaningful work,” said Freyre.

The funds shall be used to recruit physicians and scientists, and supply resources for advanced equipment, clinical and laboratory space and support staff.